Tekrarlayan prostat biyopsilerinin komplikasyon oranlarına etkisi

Amaç: Tekrarlayan transrektal ultrasonografi eşliğinde yapılan prostat biyopsilerinin komplikasyon oranlarına etkisinin olup olmadığı inceledik. Gereç ve Yöntem: Haziran 2010-Haziran 2014 tarihleri arasında transrektal ultrasonografi eşliğinde prostat biyopsisi yapılan 793 hasta çalışmaya dahil edildi. Hastalar ilk defa (Grup-1) ve daha önce biyopsi yapılanlar (Grup-2) olarak ikiye ayrıldı. Biyopsi sonrası her iki grup arasındaki komplikasyon oranları değerlendirildi. p

The effect of repeated prostate biopsies to complication rates

Aim: We examined the effect of repeated transrectal ultrasound guided prostate biopsies to complication rates. Materials and Methods: Seven hundred and ninety three patients who underwent transrectal ultrasound guided prostate biopsies between June 2010 and June 2014 were enrolled in the study. The patients divided into two groups: Patients who were biopsied for the first time (Group-1) and who were biopsied previously (Group-2). The complication rates were evaluated between two groups. p<0.05 values were regarded as statistically significant. Results: There were 668 patients (%84.2) in Group 1 and 125 patients (%15.8) in Group-2. Minor complication rates in Group-1 and Group-2 were %67.8 and %81.6, respectively (p=0.002). Major complication rates were %1.0 in Group-1 and %4.0 in Group-2 (p=0.013). Both results were statistically significant. Hematuria and infection rates were also statistically significant between the two groups (p=0.019 and p=0.039, respectively). Conclusion: Hematuria and infection rates increase after repeated prostate biopsies. Patients should be informed and measures should be reconsidered

___

  • 1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2012;62(1):10-29.
  • 2. Durkan GC, Greene DR. Diagnostic dilemmas in ditection of prostate cancer in patients undergoing transrectal ultrasound- guided needle biopsy of the prostate. Prostate Cancer Prostatic Dis 2000;3(1):13-20.
  • 3. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142(1):71-4.
  • 4. Djavan B, Waldert M, Zlotta A, et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol 2001;166(3):856-60.
  • 5. Eskicorapci SY, Guliyev F, Islamoglu E, Ergen A, Ozen H. The effect of prior biopsy scheme on prostate cancer detection for repeat biopsy population: Results of the 14-core prostate biopsy technique. Int Urol Nephrol 2007;39(1):189-95.
  • 6. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011;59(1):61-71.
  • 7. Kam SC, Choi SM, Yoon S, et al. Complications of transrectal ultrasound-guided prostate biopsy: Impact of prebiopsy enema. Korean J Urol 2014;55(11):732-6.
  • 8. Efesoy O, Bozlu M, Çayan S, Akbay E. Complications of transrectal ultrasound-guided 12-core prostate biopsy: A single center experience with 2049 patients. Turk J Urol 2013;39(1):6-11.
  • 9. Berger AP, Gozzi C, Steiner H, et al. Complication rate of transrectal ultrasound guided prostate biopsy: A comparison among 3 protocols with 6, 10 and 15 cores. J Urol 2004;171(4):1478-80.
  • 10. Rietbergen JB, Kruger AE, Kranse R, Schröder FH. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: Evaluation of complication rates and risk factors within a population based screening program. Urology 1997;49 (6):875-80.
  • 11. Avcı A, Özgök A, Erdem H, et al. Transrektal ultrasonografi eşliğinde yapılan 12 kor prostat biyopsisinde komplikasyonlar. Üroloji Bülteni 2004;15(2):153-8.
  • 12. Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schrder FH. Complication rates and risk factors of 5802 transrectal ultrasound guided sextant biopsies of the prostate within a population-based screening program. Urology 2002;60(5):826-30.
  • 13. van den Heuvel S, Loeb S, Zhu X, et al. Complications of initial prostate biopsy in a European randomized screening trial. Am J Clin Exp Urol 2013;1(1):66-71.
  • 14. Ehdaie B, Vertosick E, Spaliviero M, et al. The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. J Urol 2014;191(3):660-4.
  • 15. van den Bergh RC, Ahmed HU, Bangma CH, Cooperberg MR, Villers A, Parker CC. Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: A systematic review. Eur Urol 2014;65(6):1023-31.
Ege Tıp Dergisi-Cover
  • ISSN: 1016-9113
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1962
  • Yayıncı: Ersin HACIOĞLU
Sayıdaki Diğer Makaleler

Henoch-Schonlein purpurası: Penis ve skrotum tutulumlu olgu

Mehmet KARACI, Zuhal ÖRNEK, Burak SEYREK, Mutlu YÜKSEK, Nazmiye YÜKSEK

Autologous stem cell transplantation as a consolidation therapy in acute myeloid leukemia patients

ASU FERGÜN YILMAZ, Ayhan DÖNMEZ, Ajda GÜNEŞ, MURAT TOMBULOĞLU

Tekrarlayan prostat biyopsilerinin komplikasyon oranlarına etkisi

Sıtkı ÜN, GÖKHAN KOÇ, HAKAN TÜRK, Yüksel YILMAZ

İmperfore hymene sekonder oluşan pelvik kitlenin hymen koruyucu cerrahi ile tedavisi

Yeşim TEKİN BAYOĞLU, Emine Selda GÜVEN GÜVENDAĞ, Figen Kır ŞAHİN

Çocuklarda kas gevşeticisiz trakeal entübasyon

Filiz AKASLAN, Ayça Tuba ÖZCAN DUMANLI, Şeyda CANLI, Fatma KARAKOÇ

Konjenital kalp cerrahisi sonrası şilotoraks tanı ve tedavisine güncel yaklaşım

Onur IŞIK, Muhammet AKYÜZ, Mehmet Fatih AYIK, Yüksel ATAY

Polikistik over sendromunda klomifen sitrat ile ovulasyon indüksiyonunun serum leptin düzeylerine etkisi

Ayşen GÜÇLÜ, ÜMİT ARSLAN NAYKI, CENK NAYKI, Mehmet KÜLHAN, Salih SADIK

Ege Üniversitesi ve Mersin Üniversitesi Tıp Fakültelerinin kan merkezlerine başvuran HBsAg negatif kan vericilerinde HBV-DNA varlığının araştırılması

Arzu BAYRAM, SEDA TEZCAN ÜLGER, Gürol EMEKDAŞ, Asu DEĞİRMENCİ, Ajdan TURHAN, Yeşim AYDINOK, Naci TİFTİK, Selda ERENSOY, Rüçhan SERTÖZ

Refrakter myelom seyrinde asit oluşumu ve intraperitoneal deksametazon tedavisine yanıt

Melda CÖMERT, Gülay ALP, Günay SAYDAM, MİNE HEKİMGİL, NAZAN ÖZSAN, Filiz BÜYÜKKEÇECİ

Primer septorinoplasti olgusunda rinolit

Göksel TURHAL, KEREM ÖZTÜRK, SERCAN GÖDE, Fazıl APAYDIN